HIVE Digital Technologies Ltd.
HIVE
Analytical Summary
HIVE Digital Technologies Ltd. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). On the positive side, Debt to Equity remains strong. Investors should exercise caution and monitor for improvement in key metrics.
8-Year Financial Trajectory
QuarterlyBullish Indicators
- Debt to EquityDebt to Equity is in the top quartile (lower is better)
Bearish Risks
- Profit Margin (%)Profit Margin (%) is in the bottom quartile
- Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q1 FY2027 Jun 30, 2026 10-Q ↗ | Q4 FY2026 Mar 31, 2026 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q4 FY2024 Mar 31, 2024 40-F ↗ | Q4 FY2023 Mar 31, 2023 10-K ↗ | Q4 FY2022 Mar 31, 2022 40-F ↗ | Q4 FY2021 Mar 31, 2021 40-F ↗ |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth YoY (%) |
73.5%
Excellent
Excellent
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Above avg (+1124%)
|
— | — | — | — | — | — | — |
| FCF Growth YoY (%) |
-72.9%
Weak
Weak
Year-over-year change in free cash flow |
— | — | — | — | — | — | — |
| Metric | Q1 FY2027 Jun 30, 2026 10-Q ↗ | Q4 FY2026 Mar 31, 2026 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q4 FY2024 Mar 31, 2024 40-F ↗ | Q4 FY2023 Mar 31, 2023 10-K ↗ | Q4 FY2022 Mar 31, 2022 40-F ↗ | Q4 FY2021 Mar 31, 2021 40-F ↗ |
|---|---|---|---|---|---|---|---|---|
| Profit Margin (%) (%) |
-180.6%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-921%)
|
— |
76.8%
Excellent
Excellent
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Above avg (+249%)
|
— | — | — | — | — |
| FCF Margin (%) (%) |
5.1%
Caution
Caution
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— |
22.4%
Excellent
Excellent
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— | — | — | — | — |
| FCF / Net Income (x) |
-0.03x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
0.29x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — | — | — |
| Metric | Q1 FY2027 Jun 30, 2026 10-Q ↗ | Q4 FY2026 Mar 31, 2026 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q4 FY2024 Mar 31, 2024 40-F ↗ | Q4 FY2023 Mar 31, 2023 10-K ↗ | Q4 FY2022 Mar 31, 2022 40-F ↗ | Q4 FY2021 Mar 31, 2021 40-F ↗ |
|---|---|---|---|---|---|---|---|---|
| Return on Common Equity (%) (%) |
-33.8%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-382%)
|
— |
6.2%
Caution
Caution
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-48%)
|
— | — | — | — | — |
| Metric | Q1 FY2027 Jun 30, 2026 10-Q ↗ | Q4 FY2026 Mar 31, 2026 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q4 FY2024 Mar 31, 2024 40-F ↗ | Q4 FY2023 Mar 31, 2023 10-K ↗ | Q4 FY2022 Mar 31, 2022 40-F ↗ | Q4 FY2021 Mar 31, 2021 40-F ↗ |
|---|---|---|---|---|---|---|---|---|
| Debt to Equity (x) |
0.00x
Excellent
↓
Excellent
Declining
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-100%)
|
0.00x
Excellent
↓
Excellent
Declining
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-100%)
|
— |
0.01x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-99%)
|
0.02x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-98%)
|
— | — | — |
| Net Debt (USD) | $-206.44M | $-21.07M | — | $-19.82M | $5.61M | — | — | — |
| Metric | Q1 FY2027 Jun 30, 2026 10-Q ↗ | Q4 FY2026 Mar 31, 2026 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q4 FY2024 Mar 31, 2024 40-F ↗ | Q4 FY2023 Mar 31, 2023 10-K ↗ | Q4 FY2022 Mar 31, 2022 40-F ↗ | Q4 FY2021 Mar 31, 2021 40-F ↗ |
|---|---|---|---|---|---|---|---|---|
| Working Capital (USD) | $136.97M | $5.41M | — | $175.76M | $158.10M | — | — | — |
| Total Equity (USD) | $422.70M | $529.36M | $560.52M | $449.14M | $259.41M | $148.12M | — | — |
| Metric | Q1 FY2027 Jun 30, 2026 10-Q ↗ | Q4 FY2026 Mar 31, 2026 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q4 FY2024 Mar 31, 2024 40-F ↗ | Q4 FY2023 Mar 31, 2023 10-K ↗ | Q4 FY2022 Mar 31, 2022 40-F ↗ | Q4 FY2021 Mar 31, 2021 40-F ↗ |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue/Turnover (USD) | $79.12M | — | $45.61M | — | — | — | — | — |
| Depreciation Expense (USD) | $53.68M | — | $22.01M | — | — | — | — | — |
| Net Income, GAAP (USD) | $-142.91M | — | $35.02M | — | — | — | — | — |
| Operating Cash Flow (USD) | $4.06M | — | $10.23M | — | — | — | — | — |
Secondary lens
Benchmark Lens
Compare HIVE against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare HIVE against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for HIVE
Debt to Equity is in the top quartile (lower is better)
Profit Margin (%) is in the bottom quartile
Return on Common Equity (%) is in the bottom quartile
Percentile Rankings
How HIVE compares to all companies
Peer Comparison
HIVE vs similar peers
Compare HIVE with peers
Stack HIVE against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced yesterday 6 years · 8 quarters